Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015

被引：0

作者：

Young June Choe

Emmanuel Vidor

Christine Manson

机构：

[1] Medical Affairs,

[2] Sanofi,undefined

[3] Global Medical Affairs,undefined

[4] Sanofi,undefined

[5] Global Pharmacovigilance,undefined

[6] Sanofi,undefined

来源：

Infectious Diseases and Therapy | 2022年 / 11卷

关键词：

Diphtheria; DTaP-IPV; Pertussis; Polio; Post-marketing surveillance; Safety; Tetanus; TETRAXIM™; Vaccines;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1479 / 1492

页数：13

共 28 条

[21] Immunogenicity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus influenzae type b vaccine (DTaP-IPV//PRP-T) administered simultaneously with a hepatitis B vaccine at two, three and four months of life
Kanra, G
Silier, T
Yurdakök, K
Yavuz, T
Baskan, S
Ulukol, B
Ceyhan, M
Özmert, E
Türkay, F
Pehlivan, T
VACCINE, 1999, 18 (9-10) : 947 - 954
[22] Post-Marketing Surveillance of Hepatitis A Virus Vaccine (AvaximA® 160U) in South Korea from 2011 to 2015
Kim, HeeSoo
Oh, Yongho
Thollot, Yael
Bravo, Catherine
INFECTIOUS DISEASES AND THERAPY, 2019, 8 (01) : 105 - 112
[23] Post-Marketing Surveillance of Hepatitis A Virus Vaccine (Avaxim® 160U) in South Korea from 2011 to 2015
HeeSoo Kim
Yongho Oh
Yael Thollot
Catherine Bravo
Infectious Diseases and Therapy, 2019, 8 : 105 - 112
[24] Immunogenicity and Safety of an Investigational Hexavalent Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus-hepatitis B-Haemophilus influenzae B Conjugate Combined Vaccine in Healthy 2-, 4-, and 6-month-old Argentinean Infants
Tregnaghi, Miguel W.
Zambrano, Betzana
Santos-Lima, Eduardo
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (06) : E88 - E96
[25] Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12–23 months
Fred Zepp
Ulrich Behre
Klaus Kindler
Karl-Heinz Laakmann
Heidemarie Pankow-Culot
Wilma Mannhardt-Laakmann
François Beckers
Dominique Descamps
Paul Willems
European Journal of Pediatrics, 2007, 166 : 857 - 864
[26] Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months
Zepp, Fred
Behre, Ulrich
Kindler, Klaus
Laakmann, Karl-Heinz
Pankow-Culot, Heidemarie
Mannhardt-Laakmann, Wilma
Beckers, Francois
Descamps, Dominique
Willems, Paul
EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (08) : 857 - 864
[27] Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev®) in South Korea, 2015–2019
Hee Soo Kim
Yongho Oh
Joanna Korejwo
Valérie Bosch Castells
Kuhyun Yang
Infectious Diseases and Therapy, 2020, 9 : 589 - 598
[28] Post-Marketing Surveillance of Adverse Events Following Vaccination with the Live-Attenuated Japanese Encephalitis Chimeric Virus Vaccine (Imojev(R)) in South Korea, 2015-2019
Kim, Hee Soo
Oh, Yongho
Korejwo, Joanna
Castells, Valerie Bosch
Yang, Kuhyun
INFECTIOUS DISEASES AND THERAPY, 2020, 9 (03) : 589 - 598

← 1 2 3 →